Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis

Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial

(2018) Rui Almeida Pinto et al.   JOURNAL OF UROLOGY

Direct central nervous system effects of botulinum neurotoxin

(2018) Matteo Caleo et al.   TOXICON

Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network

(2018) J. Quentin Clemens et al.   Nature Reviews Urology

A practical approach to the management of nocturia

(2017) Matthias Oelke et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome

(2017) Yao-Chi Chuang et al.   JOURNAL OF UROLOGY

Action mechanisms of Onabotulinum toxin-A: hints for selection of eligible patients

(2017) Carlo Lovati et al.   NEUROLOGICAL SCIENCES

Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States

(2016) Shilpadevi Patil et al.   Current Pain and Headache Reports

Intravesical treatment for interstitial cystitis/painful bladder syndrome: a network meta-analysis

(2016) Wei Zhang et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Efficacy and safety of botulinum toxin injection for interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis

(2016) Sung Ryul Shim et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society

(2016) Regula Doggweiler et al.   NEUROUROLOGY AND URODYNAMICS

Use of Botulinum Toxin in Urologic Diseases

(2016) Christopher J. Chermansky et al.   UROLOGY

Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons

(2016) Ewa Bomba-Warczak et al.   Cell Reports

Botulinum toxin A for the Treatment of Overactive Bladder

(2016) Po-Fan Hsieh et al.   Toxins

Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis

(2016) Bin Chiu et al.   Toxins

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain

(2016) Duarte Machado et al.   Toxins

Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies

(2016) Junpeng Wang et al.   MEDICAL SCIENCE MONITOR

Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial

(2015) Hann-Chorng Kuo et al.   NEUROUROLOGY AND URODYNAMICS

Botulinum Toxin Type A as a Therapeutic Agent against Headache and Related Disorders

(2015) Siro Luvisetto et al.   Toxins

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

(2015) Hyun-Mi Oh et al.   Toxins

Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection

(2015) Jia-Fong Jhang et al.   Toxins

Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing

(2015) Sabine Pellett et al.   Toxins

A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome

(2013) Jane Manning et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Botulinum Toxin Type A Reduces Hyperalgesia and TRPV1 Expression in Rats with Neuropathic Pain

(2013) Lizu Xiao et al.   PAIN MEDICINE

822 RANDOMIZED CONTROLLED TRIAL FOR EFFICACY OF BOTULINUM TOXIN TYPE A IN TREATMENT OF PATIENTS SUFFERING BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS WITH HUNNERS' LESIONS PRELIMINARY RESULTS

(2012) George Kasyan et al.   JOURNAL OF UROLOGY

The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes

(2012) Sara Marinelli et al.   PLoS One

Contemporary Management of the Painful Bladder: A Systematic Review

(2011) Antonella Giannantoni et al.   EUROPEAN UROLOGY

Updates on the antinociceptive mechanism hypothesis of botulinum toxin A

(2011) K. Roger Aoki et al.   PARKINSONISM & RELATED DISORDERS

641 A PROSPECTIVE RANDOMIZED STUDY OF INTRAVESICAL PENTOSAN POLYSULFATE AND BOTULINUM TOXIN-A FOR THE TREATMENT OF PAINFUL BLADDER SYNDROME/INERSTITIAL CYSTITIS

(2010) Rasheed M. Tana et al.   EUROPEAN UROLOGY SUPPLEMENTS

Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome/interstitial cystitis: a systematic review

(2010) Sahithi Tirumuru et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome

(2010) Henry P. Gottsch et al.   NEUROUROLOGY AND URODYNAMICS

Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome

(2009) Hann-Chorng Kuo et al.   BJU INTERNATIONAL

Long-Distance Retrograde Effects of Botulinum Neurotoxin A

(2008) F. Antonucci et al.   JOURNAL OF NEUROSCIENCE

Intraprostatic Botulinum Toxin A Injection Inhibits Cyclooxygenase-2 Expression and Suppresses Prostatic Pain on Capsaicin Induced Prostatitis Model in Rat

(2008) Yao-Chi Chuang et al.   JOURNAL OF UROLOGY

Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal

(2007) Joop P. van de Merwe et al.   EUROPEAN UROLOGY